A randomized controlled study comparing once-weekly to every-2-week and every-4-week dosing of epoetin alfa in CKD patients with anemia

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 4, 2010, Pages 598-606

  Pergola, Pablo E ^a   Gartenberg, Gary ^b   Fu, Min ^b   Sun, Steven ^b   Wolfson, Marsha ^c   Bowers, Peter ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ACUTE KIDNEY FAILURE; ADULT; ADVERSE OUTCOME; AGED; ANEMIA; ARTICLE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DEATH; DEVICE; DIALYSIS; DOSAGE SCHEDULE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG WITHDRAWAL; EDEMA; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; HYPERKALEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POINT OF CARE TESTING; THORAX PAIN; THROMBOEMBOLISM; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; EPOETIN ALFA; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; IRON COMPOUNDS; KIDNEY DISEASES; MALE; MIDDLE AGED; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THROMBOEMBOLISM; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 77950939548     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06770909     Document Type: Article

References (24)

1. Drawz P, Rahman M: In the clinic. Chronic kidney disease. Ann Intern Med 150: ITC2-1-15: quiz ITC12-16, 2009
2. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J: Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 162: 1401-1408, 2002 (Pubitemid 34655201)
3. Holland DC, Lam M: Predictors of hospitalization and death among pre-dialysis patients: A retrospective cohort study. Nephrol Dial Transplant 15: 650-658, 2000 (Pubitemid 30242983)
4. Levin A, Djurdjev O, Duncan J, Rosenbaum D, Werb R: Haemoglobin at time of referral prior to dialysis predicts survival: An association of haemoglobin with long-term outcomes. Nephrol Dial Transplant 21: 370-377, 2006 (Pubitemid 43159990)
5. Klang B, Bjorvell H, Clyne N: Quality of life in predialytic uremic patients. Qual Life Res 5: 109-116, 1996 (Pubitemid 26100508)
6. Teehan BP, Benz RL, Sigler MH, Brown JM: Early intervention with recombinant human erythropoietin therapy. Semin Nephrol 10: 28-34, 1990 (Pubitemid 20173908)
7. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 27: 347-354, 1996 (Pubitemid 26075843)
8. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibo-vitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Gavish D, Baruch R, Koifman B, Kaplan C, Steinbruch S, Iaina A: The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 35: 1737-1744, 2000 (Pubitemid 30342851)
9. Pickett JL, Theberge DC, Brown WS, Schweitzer SU, Nissenson AR: Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis 33: 1122-1130, 1999
10. McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, Tse TF, Wasserman B, Leiserowitz M: The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 20: 1501-1510, 2004 (Pubitemid 39361354)
11. Nissenson AR: Novel erythropoiesis stimulating protein for managing the anemia of chronic kidney disease. Am J Kidney Dis 38: 1390-1397, 2001 (Pubitemid 34193133)
12. Maxwell AP: Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure. Kidney Int 62: 720-729, 2002 (Pubitemid 34779787)
13. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Dis 37: S182-S238, 2001 [erratum appears in Am J Kidney Dis 38: 442, 2001]
14. McGowan T, Vaccaro NM, Beaver JS, Massarella J, Wolfson M: Pharmacokinetic and pharmacodynamic profiles of extended dosing of epoetin alfa in anemic patients who have chronic kidney disease and are not on dialysis. Clin J Am Soc Nephrol 3: 1006-1014, 2008
15. Spinowitz B, Germain M, Benz R, Wolfson M, McGowan T, Tang KL, Kamin M: A randomized study of extended dosing regimens for initiation of epoetin alfa treatment for anemia of chronic kidney disease. Clin J Am Soc Nephrol 3: 935-937, 2008
16. Piccoli A, Malagoli A, Komninos G, Pastori G: Subcutaneous epoetin-alpha every one, two, and three weeks in renal anemia. J Nephrol 15: 565-574, 2002 (Pubitemid 35396522)
17. Provenzano R, Bhaduri S, Singh AK, Group PS: Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: The PROMPT study. Clin Nephrol 64: 113-123, 2005 (Pubitemid 41079007)
18. Lim VS, Kirchner PT, Fangman J, Richmond J, DeGowin RL: The safety and the efficacy of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency. Am J Kidney Dis 14: 496-506, 1989 (Pubitemid 20057897)
19. Provenzano R, Garcia-Mayol L, Suchinda P, Von Hartitzsch B, Woollen SB, Zabaneh R, Fink JC, Group PS: Once-weekly epoetin alfa for treating the anemia of chronic kidney disease. Clin Nephrol 61: 392-405, 2004 (Pubitemid 38787334)
20. Benz R, Schmidt R, Kelly K, Wolfson M: Epoetin alfa once every 2 weeks is effective for initiation of treatment of anemia of chronic kidney disease. Clin J Am Soc Nephrol 2: 215-221, 2007
21. Germain M, Ram CV, Bhaduri S, Tang KL, Klausner M, Curzi M: Extended epoetin alfa dosing in chronic kidney disease patients: A retrospective review. Nephrol Dial Transplant 20: 2146-2152, 2005 (Pubitemid 41510090)
22. Pergola P, Gartenberg G, Fu M, Wolfson M, Rao S, Bowers P: A randomized controlled study of weekly and every-2-week dosing of epoetin alfa in CKD patients with anemia. Clin J Am Soc Nephrol 4: 1731-1740, 2009
23. Locatelli F, Olivares J, Walker R, Wilkie M, Jenkins B, Dewey C, Gray SJ: Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency. Kidney Int 60: 741-747, 2001 (Pubitemid 32678918)
24. Macdougall IC, Walker R, Provenzano R, de Alvaro F, Locay HR, Nader PC, Locatelli F, Dougherty FC, Beyer U: C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: Results of a randomized clinicaltrial. Clin J Am Soc Nephrol 3: 337-347, 2008